...D-dimer. Alere (formerly Inverness Medical Inc.) gained the Triage products through its 2007 acquisition of Biosite Inc....

...Medical Systems Inc./ Roche (SIX:ROG; OTCQX:RHHBY) 6/25/07 $51.74 $75.00 1/22/08 $85.33 $89.50 73% 19% 5% Biosite Inc./...

...Biosite Inc. subsidiary voluntarily recalled one lot of its Triage Cardiac Panel to diagnose myocardial infarction. Biosite...

...B.C. Business: Supply/Service, Diagnostic Appointed: Kenneth Buechler, former president of Inverness Medical Innovations Inc. 's Biosite Inc....

...Inverness' Biosite Inc. subsidiary will develop and select antibodies that bind to Compugen's CGEN-144 , a variant...
...variant of troponin 1. Troponin 1 is a biomarker used to diagnose myocardial infarction (MI). Biosite...

...connection with the September MEDX deal, Oxford Genome also expanded on a 2006 deal with Biosite Inc....
...develop companion diagnostics for Oxford Genome's antibody therapeutics using jointly selected cancer targets from OGAP. Biosite...

...Corp. (QDEL), San Diego, Calif. Business: Diagnostic Appointed: Kenneth Buechler, formerly president and CSO of Biosite Inc. WIR...

...Biosite will receive rights to Oxford Genome's colorectal and ovarian cancer targets for diagnostic uses. Biosite...

...it did not already own for $92.50 per share in cash (see BioCentury, May 21). Biosite Inc....

...Anatomy of a bidding war From a position of wanting to go it alone, Biosite's board...
...reported in the SEC filings, in which the identities of several players are masked. Source: Biosite's...